AccelBio secures La Caixa Health Research Grant in collaboration with Marc Veldhoen to develop a targeted immune modulation strategy - AccelBio

In a groundbreaking project funded by the La Caixa Foundation, AccelBio and Marc Veldhoen’s team, from GiMM, have joined forces to explore a novel strategy for selectively modulating T cell responses. Infectious and inflammatory diseases, whose global prevalence is on the rise, remain among the leading causes of mortality worldwide. Many of these conditions are linked to the activity of T cells, a type of white blood cell critical for coordinating immune responses against pathogens. However, T c